Features of the clinical course of a new coronavirus infection in students who were observed in the observator in the first and second wave of morbidity increasing

Abstract

INTRODUCTION: The sudden appearance of a new coronavirus infection in the world has posed difficult challenges for science to determine the main clinical manifestations of this disease, as well as to approve standards for diagnosis, treatment and prevention. Research of the symptoms of mild COVID-19 is continuing. The data obtained in such studies are particularly relevant for primary care physicians.

THE AIM: To evaluate the features of the clinical course of COVID-19 among students of the North-Western State Medical University named after I.I. Mechnikov, placed in the observatory, during the first and second waves of rising morbidity.

MATERIALS AND METHODS: The study was conducted on the basis of the observatory of the NWSMU named after I.I. Mechnikov in two stages: in the period from 21.04.2020 to 31.08.2020 (the first wave) and from 16.09.2020 to 31.12.2020 (the second wave). Demographic, epidemiological, and clinical-anamnestic data were recorded in all participants of the study.

RESULTS: The study involved 309 people: 39.8% men (n = 123) and 58.9% women (n = 182). The average age of the respondents was 21.5 ± 2.6 years. The number of participants in the first and second waves was 113 and 196 people, respectively. The average age of participants with COVID-19 in the first wave was 1.5 years less and was 21.2 ± 2.5 years (р < 0.001). There was a significant increase in the frequency of the following symptoms: dry cough, loss of smell, headache, general weakness, increased body temperature to 38.0 °С, nasal congestion (р < 0.05) in students who were monitored in the second wave of increased incidence of COVID-19 compared to the first. The frequency of symptoms such as chest congestion, lower back pain, and fever above 38.0 °С significantly decreased (р < 0.05). There was a significant decrease in the incidence of viral pneumonia in patients who were observed during the second wave, compared with the data obtained during the first wave (р < 0.001).

Keywords

new coronavirus infection / COVID-19 / students / observator / clinical course / symptoms / first and second waves of increased morbidity

References

[1] Coronavirus disease 2019. Update April 14, 2020 [Internet]. Available from: https://www.lecturio.com/covid-19-coronavirus-disease-2019. Accessed 24.03.2021.

[2] Coronavirus disease 2019. Update April 14, 2020 [Электронный ресурс]. Режим доступа: https://www.lecturio.com/covid-19-coronavirus-disease-2019. Дата обращения: 24.03.2021.

[3] Perez-Saez J, Lauer S, Kaiser L, et al. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020;21(4):e69–e70. DOI: 10.1016/S1473-3099(20)30584-3

[4] Perez-Saez J., Lauer S., Kaiser L. et al. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland // Lancet Infect. Dis. 2020. Vol. 21, No. 4. P. e69–e70. DOI: 10.1016/S1473-3099(20)30584-3

[5] Gold MP, Sehayek D, Gabrielli S, et al. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132(8):749–755. DOI: 10.1080/00325481.2020.1786964

[6] Gold M.P., Sehayek D., Gabrielli S. et al. COVID-19 and comorbidities: a systematic review and meta-analysis // Postgrad. Med. 2020. Vol. 132, No. 8. P. 749–755. DOI: 10.1080/00325481.2020.1786964

[7] Jain V, Yuan J-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533–546. DOI: 10.1007/s00038-020-01390-7

[8] Jain V., Yuan J.-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis // Int. J. Public Health. 2020. Vol. 65, No. 5. P. 533–546. DOI: 10.1007/s00038-020-01390-7

[9] Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID–19) [Internet]. Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Временные_МР_COVID-19_%28v.10%29-08.02.2021_%281%29.pdf. Accessed 24.03.2021. (In Russ.)

[10] Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) [Электронный ресурс]. Режим доступа https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Временные_МР_COVID-19_%28v.10%29-08.02.2021_ %281%29.pdf. Дата обращения: 24.03.2021.

[11] Chakraborty G, Sharma AR, Sharma G, et al. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016–4026. DOI: 10.26355/eurrev_202004_20871

[12] Chakraborty G., Sharma A.R., Sharma G. et al. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options // Eur. Rev. Med. Pharmacol. Sci. 2020. Vol. 24, No. 7. P. 4016–4026. DOI: 10.26355/eurrev_202004_20871

[13] The epidemiological characteristics of an outbreak of 2019 novel Coronavirus Diseases (COVID-19). China CDC Weekly. 2020;2(8):113–122. DOI:10.46234/ccdcw2020.032

[14] The epidemiological characteristics of an outbreak of 2019 novel Coronavirus Diseases (COVID-19) // China CDC Weekly. 2020. Vol. 2, No. 8. P. 113–122. DOI:10.46234/ccdcw2020.032

[15] Kuznetsova OYu, Lyubimova AV, Ovakimyan KV, et al. Features of the clinical course of a new coronavirus infection in students who were under observation in the observatory. Russian family doctor. 2020;24(4):5–12. (In Russ.) DOI: 10.17816/RFD57155

[16] Кузнецова О.Ю., Любимова А.В, Овакимян К.В. и др. Особенности клинического течения новой коронавирусной инфекции у студентов, находившихся под наблюдением в обсерваторе // Российский семейный врач. 2020. T. 24, № 4. С. 5–12. DOI: 10.17816/RFD57155

[17] Iftimie S, López-Azcona AF, Vallverdú I, et al. First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain [Internet]. Available from: https://doi.org/10.1101/2020.12.10.20246959. Accessed 23.03.2021.

[18] Iftimie S., López-Azcona A.F., Vallverdú I. et al. First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain [Электронный ресурс]. Режим доступа: https://doi.org/10.1101/2020.12.10.20246959. Дата обращения: 23.03.2021.

[19] Sayganov SA, Meltser AV, Liubimova AV, et al. Experience in measures development to prevent spread of new coronavirus disease among students of educational organization living in dormitories. Preventive and clinical medicine. 2020;76(3):4–11. (In Russ.)

[20] Сайганов С.А., Мельцер А.В., Любимова А.В. и др. Опыт организации мер по предотвращению распространения новой коронавирусной инфекции среди обучающихся образовательной организации, проживающих в общежитиях // Профилактическая и клиническая медицина. 2020. Т. 76, № 3. С. 4–11.

[21] Klinicheskoe issledovanie preparatov dlya lecheniya COVID-19 “Solidarity”. WHO [Internet]. Available from: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Accessed 23.03.2021.

[22] Клиническое исследование препаратов для лечения COVID-19 «Solidarity» // ВОЗ [Электронный ресурс]. Режим доступа: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Дата обращения: 23.03.2021.

[23] EVMS Critical care protocol COVID19 [Internet]. Available from: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf. Accessed 23.03.2021.

[24] EVMS Critical care protocol COVID19 [Электронный ресурс]. Режим доступа: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf. Дата обращения: 23.03.2021.

[25] Meng X, Deng Ya, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. DOI: 10.1016/j.amjoto.2020.102581

[26] Meng X., Deng Ya., Dai Z., Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge // Am. J. Otolaryngol. 2020. Vol. 41, No. 5. P. 102581. DOI: 10.1016/j.amjoto.2020.102581

[27] Reinhard A, Ikonomidis Ch, Broome M, Gorostidi F. Anosmia and COVID-19. Rev Med Suisse. 2020;16(691-2):849–851. (In French)

[28] Reinhard A., Ikonomidis Ch., Broome M., Gorostidi F. Anosmia and COVID-19 // Rev. Med. Suisse. 2020. Vol. 16, No. 691-2. Р. 849–851. (In French)

[29] Vaira LA, Salzano G, Fois AG, et al. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103–1104. DOI: 10.1002/alr.22593

[30] Vaira L.A. Salzano G., Fois A.G. et al. Potential pathogenesis of ageusia and anosmia in COVID-19 patients // Int. Forum Allergy Rhinol. 2020. Vol. 10, No. 9. Р. 1103–1104. DOI: 10.1002/alr.22593

RIGHTS & PERMISSIONS

Kuznetsova O.Y., Lubimova A.V., Ovakimyan K.V., Frolova O.I., Zamyatina O.S., Durkin S.O.